Informação sobre produto
Nome:
Docosahexaenoyl ethanolamide
Sinónimos:
- (4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-Hydroxyethyl)-4,7,10,13,16,19-docosahexaenamide
- 4,7,10,13,16,19-Docosahexaenamide, N-(2-hydroxyethyl)-, (4Z,7Z,10Z,13Z,16Z,19Z)-
- Synaptamide
- (4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-Hydroxyethyl)docosa-4,7,10,13,16,19-hexaenamide
- 4,7,10,13,16,19-Docosahexaenamide, N-(2-hydroxyethyl)-, (all-Z)-
Descrição:
Docosahexaenoyl ethanolamide is a cyclase inhibitor that has been shown to have anorexigenic effects in mice. This compound inhibits the synthesis of pro-inflammatory cytokines and chemokines, which may be due to its ability to block toll-like receptor signaling pathways. Docosahexaenoyl ethanolamide also has been shown to increase the activity of PPARα, which regulates lipid and glucose metabolism. The physiological function of docosahexaenoyl ethanolamide is not well understood and further research is needed.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
371.56 g/mol
Fórmula:
C24H37NO2
Pureza:
Min. 95%
InChI:
InChI=1S/C24H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h3-4,6-7,9-10,12-13,15-16,18-19,26H,2,5,8,11,14,17,20-23H2,1H3,(H,25,27)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-
Chave InChI:
InChIKey=GEEHOLRSGZPBSM-KUBAVDMBSA-N
SMILES:
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCO
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
